Pharmacological Restoration of Diabetic Vascular Dysfunction

糖尿病血管功能障碍的药理恢复

基本信息

  • 批准号:
    9275386
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-10-01 至 2017-09-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Problem: Diabetes (DM) increases cardiovascular (CV) and all-cause mortality despite aggressive risk factor modification. Our long term goal is to define novel targets for cardiovascular risk reduction in diabetes. Vascular mitochondria are a potential new target. Mitochondria regulate endothelial function and smooth muscle cell (SMC) proliferation and mitochondrial dysfunction is a hallmark of diabetes. Exercise elicits an adaptive improvement in mitochondrial quality in healthy vessels; this response is absent in diabetes. The question addressed in this proposal is whether pharmacological targeting of eNOS and SIRT with glucagon- like peptide 1 (GLP-1) can restore signaling to mitochondrial biogenesis and improve mitochondrial dynamics and vascular function. GLP-1 is a diabetes medication that also induces eNOS, SIRT1, mitochondrial biogenesis and autophagy 21. New preliminary data suggest that saxagliptin (SAXA), a dipeptidyl peptidase-4 inhibitor that increases circulating endogenous GLP-1, restores induction of eNOS and mitochondrial protein expression with exercise in DM and improves running distance. Hypotheses: Abnormal mitochondrial function and impaired stress mediated mitochondrial dynamics in the diabetic vasculature will be improved by GLP-1 via eNOS and SIRT1 signaling. SA #1: What is the impact of GLP-1 on vascular mitochondrial adaptation in DM? Rationale: Control rats subjected to 8 day exercise show increased activation of the mitochondrial biogenesis, improved mitochondrial function plus increased fusion and decreased fission. We will examine the impact of GLP-1 on vascular mitochondrial function and turnover in diabetes and use targeted deletion of eNOS, endothelial cell (EC) SIRT1, SMC SIRT1 with or without exercise to test mitochondrial homeostatic adaptation in vivo. Hypothesis 1.1: Intervention with GLP-1 will improve mitochondrial function through augmentation of vascular mitochondrial adaptation (biogenesis, fusion and autophagy) to exercise in high fat induced diabetes. Hypothesis 1.2: eNOS and/or SIRT1 are required for GLP-1 rescue of mitochondrial adaptation. Approach: 1a. Male C57BL6 on chow versus high fat (HF) diet for 10 weeks will be randomized to GLP-1 or vehicle with or without exercise for 8 days. 1b. c57eNOS -/- and c57b eNOS +/+ will be treated as in SA1a. 1c. c57 mice with EC or SMC deletion of SIRT1 and controls will be treated as in SA1a. These experiments will clarify the importance of eNOS and SIRT1 for vascular mitochondrial adaptation to exercise in vivo and define the impact of diabetes and GLP-1 on these pathways. SA #2: How does diabetes affect dynamic mitochondrial adaptation in vascular cells in vitro? Rationale: Regulation of mitochondrial function requires a complex interplay between mitochondrial biogene- sis and remodeling through fission, fusion and autophagy. Hypothesis 2.1: Endothelial cells and/or smooth muscle cells from DM models will have impaired mitochondrial dynamics. Hypothesis 2.2: GLP-1 will improve mitochondrial function and dynamics in DM cells through eNOS and/or SIRT. Approach: These experiments will examine the impact of DM and GLP-1 on mitochondrial quality and dynamics in vitro and employ genetic approaches to define the relative contribution of eNOS and SIRT for mitochondrial quality in vascular cells. Impact on the Veteran Population: Mitochondrial dynamics are a novel target to decrease excess CV risk in diabetes. Interventions targeting mitochondrial ROS have been consistently ineffective in human studies. Our observation that 8 days of treatment with SAXA restores vascular induction of mitochondrial biogenesis provides proof of concept that impaired vascular mitochondrial adaptation is targetable with a currently available drug. Pharmacological restoration of mitochondrial dynamics in diabetes could have implications for macrovascular and microvascular complications of diabetes.
描述(由申请人提供): 问题:糖尿病(DM)增加心血管(CV)和全因死亡率,尽管积极的风险因素修改。我们的长期目标是确定降低糖尿病心血管风险的新靶点。血管线粒体是一个潜在的新靶点。线粒体调节内皮功能和平滑肌细胞(SMC)增殖,并且线粒体功能障碍是糖尿病的标志。运动可以使健康血管的线粒体质量得到适应性改善;这种反应在糖尿病患者中是不存在的。该提案中解决的问题是用胰高血糖素样肽1(GLP-1)药理学靶向eNOS和SIRT是否可以恢复线粒体生物发生的信号传导并改善线粒体动力学和血管功能。GLP-1是一种糖尿病药物,也可诱导eNOS、SIRT 1、线粒体生物合成和自噬21。新的初步数据表明,沙格列汀(SAXA),一种二肽基肽酶-4抑制剂,增加循环内源性GLP-1,恢复诱导eNOS和线粒体蛋白表达与运动DM和改善跑步距离。 假设条件:GLP-1通过eNOS和SIRT 1信号传导改善糖尿病血管系统中异常的线粒体功能和受损的应激介导的线粒体动力学。 SA #1:GLP-1对DM患者血管线粒体适应性的影响是什么?基本原理:进行8天运动的对照大鼠显示线粒体生物发生的活化增加,线粒体功能改善加上融合增加和分裂减少。我们将研究GLP-1对糖尿病患者血管线粒体功能和周转的影响,并使用eNOS、内皮细胞(EC)SIRT 1、SMC SIRT 1的靶向缺失,在运动或不运动的情况下测试体内线粒体稳态适应。假设1.1:GLP-1的干预将通过增强血管线粒体适应(生物发生、融合和自噬)来改善线粒体功能,以在高脂肪诱导的糖尿病中进行运动。假设1.2:eNOS和/或SIRT 1是GLP-1拯救线粒体适应所必需的。方法:1a.将接受普通饲料与高脂肪(HF)饮食10周的雄性C57 BL 6随机分配至GLP-1或溶媒组,伴或不伴运动8天。1b. c57 eNOS-/-和c57 b eNOS +/+将按照SA 1a进行处理。1c.具有SIRT 1的EC或SMC缺失的c57小鼠和对照将如SA 1a中那样处理。这些实验将阐明eNOS和SIRT 1对血管线粒体适应体内运动的重要性,并确定糖尿病和GLP-1对这些途径的影响。 SA #2:糖尿病如何影响体外血管细胞的动态线粒体适应?基本原理:线粒体功能的调节需要线粒体生物合成与通过分裂、融合和自噬的重塑之间的复杂相互作用。假设2.1:来自DM模型的内皮细胞和/或平滑肌细胞将具有受损的线粒体动力学。假设2.2:GLP-1将通过eNOS和/或SIRT改善DM细胞中的线粒体功能和动力学。方法:这些实验将检查DM和GLP-1对体外线粒体质量和动力学的影响,并采用遗传方法来确定eNOS和SIRT对血管细胞线粒体质量的相对贡献。 对退伍军人人群的影响:线粒体动力学是降低糖尿病患者过度CV风险的新靶点。针对线粒体ROS的干预措施在人类研究中一直无效。我们观察到,用SAXA治疗8天恢复了线粒体生物发生的血管诱导,这提供了概念证据,即受损的血管线粒体适应是目前可用药物的靶向。糖尿病线粒体动力学的药理学恢复可能对糖尿病的大血管和微血管并发症有影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JANE E REUSCH其他文献

JANE E REUSCH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JANE E REUSCH', 18)}}的其他基金

Impact of SARS CoV2 on post-hospital recovery of carbohydrate and muscle metabolism: role of endothelial injury
SARS CoV2 对出院后碳水化合物和肌肉代谢恢复的影响:内皮损伤的作用
  • 批准号:
    10319430
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Incidence and severity of new onset diabetes associated with SARS-CoV-2 infection
与 SARS-CoV-2 感染相关的新发糖尿病的发病率和严重程度
  • 批准号:
    10632720
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
P and F Program
P 和 F 计划
  • 批准号:
    10392982
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
P and F Program
P 和 F 计划
  • 批准号:
    10646163
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
糖尿病运动不耐受的心血管机制和性别的作用
  • 批准号:
    10579851
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
糖尿病运动不耐受的心血管机制和性别的作用
  • 批准号:
    10451482
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Cardiovascular Mechanisms of Exercise Intolerance in Diabetes and the Role of Sex
糖尿病运动不耐受的心血管机制和性别的作用
  • 批准号:
    9348778
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Pharmacological Restoration of Diabetic Vascular Dysfunction
糖尿病血管功能障碍的药理恢复
  • 批准号:
    8811828
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Pharmacological Restoration of Diabetic Vascular Dysfunction
糖尿病血管功能障碍的药理恢复
  • 批准号:
    8966651
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
Targeting Microvascular Contributors to Impaired Functional Exercise Capacity in Diabetes
针对糖尿病患者功能运动能力受损的微血管贡献者
  • 批准号:
    9898228
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了